# mRNA-1010

Type: Product

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/mrna-1010
Canonical HTML page: https://gethealthbrief.com/entity/mrna-1010

## Timeline

- **2026-02-18**: Regulatory U-Turn — The FDA officially agrees to consider the application after resolving the internal and public dispute.
- **2026-02-12**: Public Dispute — Reports emerge that career FDA scientists were overruled, leading to a public standoff between Moderna and the agency.
- **2026-02-05**: Initial Rejection — Trump administration vaccine chief refuses to review Moderna's mRNA flu shot application.

## Recent coverage (1 stories)

### FDA Reverses Course on Moderna mRNA Flu Shot Following Public Dispute
2026-02-19 09:53:59 · Sentiment: Positive · Impact: 8/10 · Sources: 13

The FDA has agreed to review Moderna’s mRNA-based influenza vaccine after a high-profile rejection by the Trump administration's vaccine chief. The reversal follows a public dispute where scientific staff were reportedly overruled, marking a significant shift for the first-of-its-kind vaccine candidate.
Full story: https://gethealthbrief.com/story/fda-moderna-flu-shot-reversal

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.